Gerald Beste

This inventor holds 21 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Immunoglobulin Technology. Top assignees: Ablynx N.v., Sanofi, Merck Patent Gmbh. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald Beste. Retrieved from https://idiyas.com/inventor/gerald-beste

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 85(Granted Patents)

Company Filing History:

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Immunoglobulin

Bispecific Antibodies

Protein Interference

Polypeptides

ADAMTS5

MMP13

Aggrecan

HER3

c-Met

Nucleic Acids

A-Beta Binding

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662525 - TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS (2026-06-23),

2. 12630609 - TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS (2026-05-19),

3. 12516105 - TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS (2026-01-06),

4. 12195546 - CD28/OX40 bispecific antibodies (2025-01-14),

5. 12129308 - MMP13 binding immunoglobulins (2024-10-29),

6. 12006352 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2024-06-11),

7. 11813307 - Polypeptides binding ADAMTS5, MMP13 and aggrecan (2023-11-14),

8. 11644471 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2023-05-09),

9. 11603401 - Aggrecan binding immunoglobulins (2023-03-14),

10. 11248055 - Polypeptides inhibiting CD40L (2022-02-15),

11. 11192938 - Serum albumin binding proteins containing immunoglobulin single variable domains (2021-12-07),

12. 11192937 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2021-12-07),

13. 10858418 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2020-12-08),

14. 10808032 - Biological materials related to HER3 (2020-10-20),

15. 9932403 - Biological materials related to HER3 (2018-04-03),

Title: The Innovative Journey of Inventor Gerald Beste

Introduction: Gerald Beste is a pioneering inventor based in Ghent, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Gerald Beste holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights: With a career spanning over two decades, Gerald Beste has established himself as a leading figure in the innovation landscape. His work has been instrumental in shaping the way we interact with technology on a daily basis.

Collaborations: Throughout his career, Gerald Beste has collaborated with top research institutions, leading companies, and visionary inventors to push the boundaries of technological innovation further. His collaborative efforts have resulted in cutting-edge solutions that have transformed industries.

Conclusion: Gerald Beste's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.